Modern technology: The preferred biosecurity strategy?

por Cox, Manon
Publicado 2017

2021 ISV Annual Virtual Congress

por Cox, Manon
Publicado 2022

Pandemic influenza: overview of vaccines and antiviral drugs.

por Cox, Manon M. J.
Publicado 2005

What to do when your technology is good but a licence is terminated

por Cox, Manon, Adams, Dan
Publicado 2005

Recombinant protein vaccines produced in insect cells

por Cox, Manon M.J.
Publicado 2012

Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production

por Cox, Manon M. J.
Publicado 2021

Production of a novel influenza vaccine using insect cells: protection against drifted strains

por Cox, Manon M. J., Karl Anderson, D.
Publicado 2007

Meet the fellows: Everything about ISV

por Doolan, Denise, Lu, Shan, Ross, Ted, Cox, Manon
Publicado 2022

FluBlok, a recombinant hemagglutinin influenza vaccine

por Cox, Manon M.J., Patriarca, Peter A., Treanor, John
Publicado 2008

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans

por Nachbagauer, Raffael, Choi, Angela, Izikson, Ruvim, Cox, Manon M., Palese, Peter, Krammer, Florian
Publicado 2016

Complete study demonstrating the absence of rhabdovirus in a distinct Sf9 cell line

por Hashimoto, Yoshifumi, Macri, Daniel, Srivastava, Indresh, McPherson, Clifton, Felberbaum, Rachael, Post, Penny, Cox, Manon
Publicado 2017

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine

por Honda-Okubo, Yoshikazu, Rajapaksha, Harinda, Sajkov, Dimitar, Gordon, David, Cox, Manon M. J., Petrovsky, Nikolai
Publicado 2017

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice

por Zhou, Zhimin, Post, Penny, Chubet, Rick, Holtz, Katherine, McPherson, Clifton, Petric, Martin, Cox, Manon
Publicado 2006

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine

por Wang, Keyang, Holtz, Kathleen M., Anderson, Karl, Chubet, Richard, Mahmoud, Wafaa, Cox, Manon M.J.
Publicado 2006

Titer on Chip: New Analytical Tool for Influenza Vaccine Potency Determination

por Kuck, Laura R., Sorensen, Michelle, Matthews, Erin, Srivastava, Indresh, Cox, Manon M. J., Rowlen, Kathy L.
Publicado 2014

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant

por McPherson, Clifton, Chubet, Richard, Holtz, Kathy, Honda-Okubo, Yoshikazu, Barnard, Dale, Cox, Manon, Petrovsky, Nikolai
Publicado 2015

Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability

por Feshchenko, Elena, Rhodes, David G, Felberbaum, Rachael, McPherson, Clifton, Rininger, Joseph A, Post, Penny, Cox, Manon MJ
Publicado 2012

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin

por Rajendran, Madhusudan, Nachbagauer, Raffael, Ermler, Megan E., Bunduc, Paul, Amanat, Fatima, Izikson, Ruvim, Cox, Manon, Palese, Peter, Eichelberger, Maryna, Krammer, Florian
Publicado 2017

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans

por Stadlbauer, Daniel, Rajabhathor, Arvind, Amanat, Fatima, Kaplan, Daniel, Masud, Abusaleh, Treanor, John J., Izikson, Ruvim, Cox, Manon M., Nachbagauer, Raffael, Krammer, Florian
Publicado 2017

Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss

por Holtz, Kathleen M, Robinson, Pamela S, Matthews, Erin E, Hashimoto, Yoshifumi, McPherson, Clifton E, Khramtsov, Nikolai, Reifler, Michael J, Meghrous, Jamal, Rhodes, David G, Cox, Manon M, Srivastava, Indresh K
Publicado 2014